FDA issues supplementary SUDs (single use devices) rules:
This article was originally published in Clinica
The US FDA has issued additional clarification of its rules controlling the reuse of single use devices. It said that manufacturers who reprocess their own single-use devices must disclose that fact to the agency. The company must also register with the FDA so inspectors know where the reprocessing is occurring and list what devices are being reprocessed, it said.
You may also be interested in...
Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.
Momenta Pharmaceuticals has agreed to pay $35.0m to settle claims that it manipulated generic approval processes in the US to shut competitor Amphastar out of the US enoxaparin market.